Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
The diflunisal trial: Update on study drug tolerance and disease progression
J. L. Berk
, P. J. Dyck
, L. Obici
, S. R. Zeldenrust
, Y. Sekijima
, T. Yamashita
, Y. Ando
, S. I. Ikeda
,
P. Gorevic
, G. Merlini
, J. W. Kelly
, M. Skinner
, A. B. Bisbee
, O. B. Suhr
Icahn School of Medicine at Mount Sinai
Medicine
Medicine - Rheumatology
Research output
:
Contribution to journal
›
Article
›
peer-review
18
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The diflunisal trial: Update on study drug tolerance and disease progression'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Disease Exacerbation
100%
Drug Induced Disease
100%
Drug Tolerance
100%
Familial Amyloid Neuropathy
100%
Diflunisal
100%
Neurologic Disease
40%
Thyroxine
40%
Liver Transplantation
20%
In Vitro
20%
Diabetes Mellitus
20%
Cohort Analysis
20%
Gastrointestinal Tract
20%
Genetic Disorder
20%
Autonomic Nervous System
20%
Peripheral Nervous System
20%
Amyloid Protein
20%
Transthyretin
20%
Fibril Formation
20%
Keyphrases
Disease Progression
100%
Familial Amyloid Polyneuropathy
100%
Drug Tolerance
100%
Diflunisal
100%
Thyroxine
40%
Neurological Diseases
40%
Liver Transplantation
20%
Peripheral Nervous System
20%
In Vitro Condition
20%
Type 1 Diabetes Mellitus (T1DM)
20%
Gastrointestinal Tract
20%
Small Molecules
20%
Autonomic Nervous System
20%
Genetic Disease
20%
Soft Tissue
20%
Amyloid Fibrillation
20%
Transthyretin
20%